Sponsors
The bill tightens HHS controls and increases GAO-framed oversight to reduce improper advance premium tax credit payments and protect consumers from later penalties, but it raises verification and administrative burdens and could expose some beneficiaries to recoupment and financial liability.
Consumers enrolled in marketplace plans and premium tax credit recipients will get more accurate eligibility decisions and be less likely to face later recoupment or penalties due to strengthened HHS controls.
Taxpayers may see reduced waste and lower costs from fewer improper advance premium tax credit payments.
Congress, the HHS Inspector General, and GAO-framed reporting will receive regular assessments that increase oversight transparency and enable corrective or legislative action on program weaknesses.
Applicants for advance premium tax credits could face stricter verification, causing enrollment delays and additional documentation burdens.
Increased scrutiny may lead to more determinations being reversed or credits recouped, creating potential financial liability for some beneficiaries.
Preparing annual GAO‑framed assessments increases HHS administrative workload and could require reallocating federal staff and resources.
Based on analysis of 2 sections of legislative text.
Requires HHS, with Treasury, to produce annual fraud-risk assessments of advance eligibility determinations for ACA premium tax credits and cost‑sharing reductions, using the GAO framework and reporting to OIG and Congress.
Requires the Department of Health and Human Services, working with the Treasury Department, to produce a fraud-risk assessment of advance eligibility determinations for Affordable Care Act premium tax credits and cost‑sharing reductions. The first assessment must be completed by December 31, 2025, and the assessment must be repeated every year thereafter. Each assessment must list the controls HHS uses to prevent fraud in advance premium tax credit claims, follow the Government Accountability Office’s fraud-risk framework, and be sent to the HHS Inspector General and specified congressional committees. The measure sets reporting and methodological requirements but does not create new spending or change tax law.
Introduced December 8, 2025 by Charles Ernest Grassley · Last progress December 8, 2025